GILD34:BVMF
Gilead Sciences Inc BDR
၆၅.၅၂ R$
၀.၀၀%
(၀.၀၀) 1D
အောက် ၂၀, GMT-၃ ၁၆:၅၆:၀၀ · BRL
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for GILD34...
Open
၆၄.၉၈ R$
High
၆၅.၅၂ R$
Low
၆၄.၉၈ R$
Mkt. cap
ဋေ ၁.၉၄ သ
Avg. vol.
၃၁၉.၀၀
Volume
၅.၀၀
52-wk high
၆၇.၃၈ R$
52-wk low
၅၁.၃၃ R$
Shares outstanding
၁၂၄.၀၀ ဋေ
No. of employees
၂ သောင်း
Open
၆၄.၉၈ R$
High
၆၅.၅၂ R$
Low
၆၄.၉၈ R$
Mkt. cap
ဋေ ၁.၉၄ သ
Avg. vol.
၃၁၉.၀၀
Volume
၅.၀၀
52-wk high
၆၇.၃၈ R$
52-wk low
၅၁.၃၃ R$
Shares outstanding
၁၂၄.၀၀ ဋေ
No. of employees
၂ သောင်း
News stories
From web sources and news partners
ad-hoc-news.de
·
ပြီးခဲ့သည့် ၉ နာရီ
Gilead Sciences stock: BofA raised target for Gilead Sciences stock to USD 164.00
Simply Wall Street
·
ပြီးခဲ့သည့် ၁၁ နာရီ
Gilead Cancer Drug Deal Might Change The Case For Investing In Vir Biotechnology (VIR)
Investing.com
·
ပြီးခဲ့သည့် ၁၃ နာရီ
BofA raises Gilead Sciences stock price target on positive trial data
MarketBeat
·
ပြီးခဲ့သည့် ၁၆ နာရီ
15,240 Gilead Sciences, Inc. $GILD Shares Bought by CWA Asset Management Group LLC
Profile
Gilead Sciences, Inc. is an American biopharmaceutical company headquartered in Foster City, California, that focuses on researching and developing antiviral drugs used in the treatment of HIV/AIDS, hepatitis B, hepatitis C, influenza, and COVID-19. It also develops medicines in therapeutic areas such as oncology and inflammation and cell therapy.
In 1987, Michael L. Riordan founded the company under the name Oligogen. The original name was a reference to oligonucleotides, small strands of DNA used to target genetic sequences. Gilead held its initial public offering in 1992, and successfully developed drugs including Tamiflu and Vistide that decade.
In the 2000s, Gilead began evolving from a biotechnology company into a large pharmaceutical company, through acquisitions and investments, acquiring several subsidiaries. Gilead is a member of the Nasdaq-100 and the S&P 100.
The company has faced criticism over its business practices, including extremely high pricing of drugs such as Sovaldi and Truvada in the United States relative to production cost and cost in the developing world. Wikipedia
About Gilead Sciences Inc BDR
CEODaniel O'Day
Employees၁.၇ သောင်း
Founded၁၉၈၇ ဇွန် ၂၂
HeadquartersFoster City, ကယ်လီဖိုးနီးယားပြည်နယ်, ယူနိုက်တက်စတိတ်
Sector-
Websitegilead.com